2015
DOI: 10.2105/ajph.2014.302490
|View full text |Cite
|
Sign up to set email alerts
|

Racial/Ethnic and Socioeconomic Disparities in Endocrine Therapy Adherence in Breast Cancer: A Systematic Review

Abstract: We examined the current literature to understand factors that influence endocrine therapy (ET) adherence among racial/ethnic and socioeconomic subpopulations of breast cancer patients. We searched PubMed and PsycINFO databases for studies from January 1, 1978, to June 20, 2014, and January 1, 1991, to June 20, 2014, respectively, and hand-searched articles from relevant literature reviews. We abstracted and synthesized results within a social ecological framework. Fourteen articles met all inclusion criteria. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
107
2

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 118 publications
(111 citation statements)
references
References 85 publications
(147 reference statements)
2
107
2
Order By: Relevance
“…This is lower than previous reports using similar claims-based methodology among non-elderly privately insured women, which reported 72–81% 12-month adherence to AET [3741]. However, unlike our study, they did not include a large proportion of low-income minority women which are factors that are associated with lower likelihood of adherence [11, 16, 17]. Studies using state cancer registry and Medicaid-linked data in North Carolina [17] and New York [42] corroborate our adherence rates and find that adherence ranges from 59 to 60% within the first year of initiation.…”
Section: Discussioncontrasting
confidence: 73%
See 2 more Smart Citations
“…This is lower than previous reports using similar claims-based methodology among non-elderly privately insured women, which reported 72–81% 12-month adherence to AET [3741]. However, unlike our study, they did not include a large proportion of low-income minority women which are factors that are associated with lower likelihood of adherence [11, 16, 17]. Studies using state cancer registry and Medicaid-linked data in North Carolina [17] and New York [42] corroborate our adherence rates and find that adherence ranges from 59 to 60% within the first year of initiation.…”
Section: Discussioncontrasting
confidence: 73%
“…Despite the effectiveness of AET to improve survival and decrease cancer recurrence, between 55–75% of breast cancer patients are not adherent to AET during 1-year period [14] and the proportion of being not adherent is even higher for minority women [15, 16]. Previous studies have examined that black patients had 24% lower odds of adherence to AET compared to non-Hispanic white women [11].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Based on the established SES-dependent variation in clinicopathological characteristics and outcomes in many diseases (Barker, 1981;Gomez et al, 2015;Stringhini et al, 2013) including cancer (DeSantis et al, 2011;Kolahdooz et al, 2014;Lyratzopoulos et al, 2012;Roberts et al, 2015;Rutherford et al, 2013), we hypothesised a role for SES in influencing the biological and clinical heterogeneity in patients with MDS. In previous studies, Wang et al (2009) investigated the prognostic role of neighbourhood SES in MDS using data from the Surveillance, Epidemiology and End Results (SEER) cancer registries linked to the national insurance programme Medicare in the USA and identified poorer survival in patients belonging to lower SES groups.…”
Section: Discussionmentioning
confidence: 99%
“…In patients with solid organ and other haematological neoplasia differences in time to diagnosis, access to clinical care or trials and comorbidity between patients that are SES-dependent are known to affect survival (Kolahdooz et al, 2014;Munro, 2005;Roberts et al, 2015;Rutherford et al, 2013). For example, the lower incidence of childhood acute lymphoblastic leukaemia across levels of increasing relative deprivation could reflect under-diagnosis in lower socioeconomic communities (Kroll et al, 2012;Lightfoot et al, 2012), and the mortality in AML and myeloma appears to be reduced in higher SES groups in some studies (Kristinsson et al, 2009).…”
Section: Introductionmentioning
confidence: 99%